Back
Brainstorm Cell Therapeutics, Inc. Stock Price Chart
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
40
BCLI
Brainstorm Cell Therapeutics, Inc.
Last Price:
$0.60
Seasonality Move:
24.38%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing selling pressure, which indicates risk of future bearish movement.
Brainstorm Cell Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.62 | Sell |
| 20-day SMA: | 0.63 | Sell |
| 50-day SMA: | 0.67 | Sell |
| 200-day SMA: | 0.96 | Sell |
| 8-day EMA: | 0.62 | Sell |
| 20-day EMA: | 0.63 | Sell |
| 50-day EMA: | 0.66 | Sell |
| 200-day EMA: | 0.89 | Sell |
Brainstorm Cell Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 41.58 | Sell |
| Chaikin Money Flow: | -26976 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.62 - 0.66) | Sell |
| Bollinger Bands (100): | (0.61 - 0.75) | Sell |
Brainstorm Cell Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics, Inc. Stock
Is Brainstorm Cell Therapeutics, Inc. Stock a Buy?
-
Brainstorm Cell Therapeutics, Inc. share price is 0.60 while BCLI 8-day simple moving average is 0.62, which is a Sell signal.
-
The stock price of BCLI is 0.60 while Brainstorm Cell Therapeutics, Inc. 20-day SMA is 0.63, which makes it a Sell.
-
Brainstorm Cell Therapeutics, Inc. 50-day simple moving average is 0.67 while BCLI share price is 0.60, making it a Sell technically.
-
BCLI stock price is 0.60 and Brainstorm Cell Therapeutics, Inc. 200-day simple moving average is 0.96, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
40
Brainstorm Cell Therapeutics, Inc. (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics, Inc. a Buy or a Sell?
-
Brainstorm Cell Therapeutics, Inc. stock is rated a SellThe current Brainstorm Cell Therapeutics, Inc. [BCLI] share price is $0.60. The Score for BCLI is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics, Inc. Stock Info
Market Cap:
6.6M
Price in USD:
0.60
Share Volume:
27K
Brainstorm Cell Therapeutics, Inc. 52-Week Range
52-Week High:
2.50
52-Week Low:
0.52
Sell
40
Brainstorm Cell Therapeutics, Inc. (BCLI)
is a Sell
Brainstorm Cell Therapeutics, Inc. Share Price Forecast
-
What is the Brainstorm Cell Therapeutics, Inc. stock price today?The Brainstorm Cell Therapeutics, Inc. stock price is 0.60 USD today.
-
Will BCLI stock go up or go down?Brainstorm Cell Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Brainstorm Cell Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics, Inc. is overvalued.
Is Brainstorm Cell Therapeutics, Inc. Stock a Buy?
-
Brainstorm Cell Therapeutics, Inc. share price is 0.60 while BCLI 8-day exponential moving average is 0.62, which is a Sell signal.
-
The stock price of BCLI is 0.60 while Brainstorm Cell Therapeutics, Inc. 20-day EMA is 0.63, which makes it a Sell.
-
Brainstorm Cell Therapeutics, Inc. 50-day exponential moving average is 0.66 while BCLI share price is 0.60, making it a Sell technically.
-
BCLI stock price is 0.60 and Brainstorm Cell Therapeutics, Inc. 200-day simple moving average is 0.89, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics, Inc.
Is Brainstorm Cell Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.10 per share.
Technical Analysis of Brainstorm Cell Therapeutics, Inc.
Should I short Brainstorm Cell Therapeutics, Inc. stock?
-
BCLI Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Brainstorm Cell Therapeutics, Inc. is a Sell
-
Brainstorm Cell Therapeutics, Inc. Relative Strength Index (RSI) is 41.58, which suggest Brainstorm Cell Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Brainstorm Cell Therapeutics, Inc. is (0.62 - 0.66), which suggest Brainstorm Cell Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Brainstorm Cell Therapeutics, Inc. is (0.61 - 0.75), which suggest Brainstorm Cell Therapeutics, Inc. is a Sell
* Brainstorm Cell Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.